CFG
XBI icon

Citizens Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Citizens Financial Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Hold
7,372
– – 0.01% 412
2026
Q1 		$942K Sell
7,372
-350
-5% -$43.7K 0.01% 405
2025
Q4 		$942K Buy
7,722
+201
+3% +$23K 0.01% 411
2025
Q3 		$754K Buy
7,521
+1,367
+22% +$123K 0.01% 458
2025
Q2 		$510K Buy
6,154
+2,197
+56% +$175K 0.01% 465
2025
Q1 		$321K Buy
3,957
+111
+3% +$9.92K 0.01% 491
2024
Q4 		$346K Sell
3,846
-125
-3% -$12.1K 0.01% 454
2024
Q3 		$392K Hold
3,971
– – 0.01% 420
2024
Q2 		$368K Buy
3,971
+825
+26% +$74K 0.01% 417
2024
Q1 		$298K Hold
3,146
– – 0.01% 338
2023
Q4 		$281K Sell
3,146
-100
-3% -$7.43K 0.01% 345
2023
Q3 		$237K Buy
3,246
+100
+3% +$7.99K 0.01% 325
2023
Q2 		$262K Buy
+3,146
New +$263K 0.01% 338
2022
Q3 		– Sell
-3,740
Closed -$278K – 437
2022
Q2 		$278K Sell
3,740
-354
-9% -$26.6K 0.01% 360
2022
Q1 		$368K Hold
4,094
– – 0.01% 328
2021
Q4 		$458K Hold
4,094
– – 0.02% 302
2021
Q3 		$515K Buy
4,094
+2,461
+151% +$317K 0.02% 282
2021
Q2 		$221K Buy
1,633
+93
+6% +$12.2K 0.01% 333
2021
Q1 		$209K Buy
+1,540
New +$231K 0.01% 303
2020
Q3 		– Sell
-596
Closed -$67K – 956
2020
Q2 		$67K Hold
596
– – ﹤0.01% 422
2020
Q1 		$46K Buy
+596
New +$52.8K ﹤0.01% 441
2019
Q2 		– Sell
-400
Closed -$36K – 864
2019
Q1 		$36K Buy
+400
New +$34K ﹤0.01% 392

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Citizens Financial Group's XBI Position: Q2 2026 in Review

Citizens Financial Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 7,372 shares worth $1.17M. The position accounts for 0.01% of the portfolio, ranked #412.

Citizens Financial Group first reported a position in XBI in Q1 2019 and has held it in 22 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Citizens Financial Group held 7,372 shares of State Street SPDR S&P Biotech ETF worth $1.17M as of Q2 2026.
  • Citizens Financial Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Citizens Financial Group's portfolio in Q2 2026, its #412 holding.
  • Citizens Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 22 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.